title: Choroid plexus taurine transport.
abstract: The putative osmoregulatory agent, taurine, is lost from the brain during hypo-osmotic stress or ischemia, but the regulatory mechanisms involved in this loss have not been fully elucidated. In this study, we have examined taurine transport by the isolated rat choroid plexus, one element of the brain-blood interface, and examined how it may be regulated as part of brain volume regulation. Choroid plexus taurine uptake was Na- and Cl-dependent with a Vmax and Km of 6.5 +/- 0.3 pmol/mg/min and 232 +/- 33 microM. The latter is substantially greater than the normal CSF taurine concentration and this may be important in removing taurine released into the CSF during parenchymal cell swelling. Taurine uptake also appears calmodulin dependent as it was reduced by 84 and 91% in the presence of 25 microM trifluoperazine and 100 microM W-7, two calmodulin inhibitors. Taurine efflux from choroid plexus was stimulated by trifluoperazine, taurine, and hypo-osmotic stress. The latter two effects were reduced by niflumic acid, suggesting that taurine and hypo-osmotic stress act on the same pathway. The stimulation of efflux by hypo-osmotic stress decreased with time, whereas the effect of external taurine was sustained. If this efflux pathway is involved in the movement of taurine from choroid plexus to blood, these results suggest that changes in extracellular taurine may be more important than the direct effect of hypo-osmolality in the long-term loss of taurine from the brain.
authors: Department of Surgery (Neurosurgery), University of Michigan, Ann Arbor 48109-0532, USA.
authors: R F
authors: RF
authors: Keep
authors: J
authors: J
authors: Xiang
mesh_terms: D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects / Q000502:physiology; D002118:Calcium / Q000502:physiology; D002147:Calmodulin / Q000037:antagonists & inhibitors; D002831:Choroid Plexus / Q000187:drug effects / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D008353:Mannitol / Q000378:metabolism; D009544:Niflumic Acid / Q000494:pharmacology; D009994:Osmolar Concentration; D009997:Osmotic Pressure; D051381:Rats; D017207:Rats, Sprague-Dawley; D013449:Sulfonamides / Q000494:pharmacology; D013654:Taurine / Q000134:cerebrospinal fluid / Q000378:metabolism*; D014268:Trifluoperazine / Q000494:pharmacology
chemical_list: D002147:Calmodulin; D016861:Cyclooxygenase Inhibitors; D018492:Dopamine Antagonists; D004791:Enzyme Inhibitors; D013449:Sulfonamides; D013654:Taurine; D014268:Trifluoperazine; D008353:Mannitol; D009544:Niflumic Acid; C017967:W 7; D002118:Calcium